Life Sciences on the Rise: 2021 North American Report

FAST OFFICE STATS 102.4 MSF MARKET SQUARE FOOTAGE $16.13 $ PER SF NNN 11.4% VACANCY 56K TOTAL LIFE SCIENCES EMPLOYMENT & TALENT POOL

MARKET SUMMARY • Montreal is the leading life sciences research and development hub in Canada in patents and R&D expenditures, with over 800 companies and 170 research centers 1 . • The region’s life sciences industry is highly diversified with organizations including traditional pharmaceuticals, medical device research and manufacturing, artificial intelligence research, and an active venture capital investor pool. • Montreal features some of the lowest research and operational costs in North America, due in part to substantial provincial tax credits 2 . • The area’s support infrastructure facilitates companies through all phases of development, from basic research to commercialization.

1 Montreal International 2 BioTalent Canada

Montreal REPRESENTATIVE LIFE SCIENCES COMPANIES

TOP NIH-FUNDED INSTITUTIONS (2016-2020) • The National Institute of Health (U.S.) provided $8.4M $USD in funding to Montreal universities and health centers in 2020. • The Quebec Life Sciences Strategy’s the province of Quebec one of the five largest North American life sciences hubs. In its 2020-2021 budget, the government allocated $118M to support the life sciences industry. main objective is to attract $4B in private investment to Quebec by 2022 and to make

COMPANY

TYPE

Bausch Health Companies

International HQ

Novartis Pharma Canada

Canadian HQ

Pharmascience Inc

International HQ

Abbott Laboratories

Canadian HQ

Merck Canada Inc

Canadian HQ

Pfizer Canada SRI

Canadian HQ

PF Consumer Healthcare Canada ULC International HQ

Source: Ministry of Economy, Innovation and Exports

Sandoz Canada Inc

Canadian HQ

Confab Laboratories Inc

International HQ

AbbVie

Research Facility

PUBLIC & PRIVATE FUNDING (2020-2021)

COMPANY

DEAL TYPE

COMPLETED

TYPE

$ RAISED (MM)

Repare Therapeutics

IPO

Jun 2020

Public

$253.0

Ventus Therapeutics

Early Stage

Apr 2021

VC

$100.0

Public Investment 2nd Offering Public Investment 2nd Offering

Theratechnologies

Jan 2021

Public

$46.0

Bellus Health

Oct 2020

Public

$40.3

Inversago

Later Stage

Sep 2020

VC

$35.0

/ 28